Key takeaways
Admelog (insulin lispro) and Basaglar (insulin glargine) are both insulins used to manage blood sugar levels in people with Type 1 and Type 2 diabetes. However, they belong to different classes of insulin. Admelog is a fast-acting insulin, typically taken with meals to quickly lower blood sugar levels, while Basaglar is a long-acting insulin that provides steady blood sugar control throughout the day and is usually taken once daily. Admelog is available in vials and pre-filled pens, whereas Basaglar comes in pre-filled pens only. Both medications can cause low blood sugar, weight gain, and injection site reactions. Neither medication has a generic version available, and both require a prescription. It's important to follow your prescriber's instructions on dosing and administration to avoid complications.
